AI eye test aims to catch diabetes blindness early

NCT ID NCT07222293

First seen Oct 31, 2025 · Last updated May 11, 2026 · Updated 29 times

Summary

This study checks if an AI program called DRISTi can correctly find signs of diabetic retinopathy (eye damage from diabetes) in 900 adults with diabetes. Participants get eye photos, which the AI and a human expert review separately. The goal is to see if the AI is accurate enough to be a reliable screening tool.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Century Ophthalmology - Oxford

    RECRUITING

    Oxford, North Carolina, 27565, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • New Century Ophthalmology - Raleigh

    RECRUITING

    Raleigh, North Carolina, 27617, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.